Dash /Al-Zarouni /Rattan /Panigrahi Med Princ Pract 2012;21:495-497 496 tient had fever, hypotension, sinus bradycardia, bilateral pleural effusion and ascites. In addition to blood product transfusion and treatment of shock, he was also started on intravenous amikacin 500 mg once daily. Three sets of aerobic blood culture specimens were positive after 48 h of incubation for the presence of microorganisms by automated microbial detection system (BacT/ALERT 3D system, bioMérieux, Durham, N.C., USA). The isolated organism was a tiny Gram-negative coccobacillus that gave positive catalase and oxidase test. The organism was identified as B. zoohelcum by the MicroScan WalkAway (Siemens Healthcare Diagnostics Inc., West Sacramento, Calif., USA) system using MicroScan NegCombo Type 44 panel with a 64% probability. Based on the blood culture reports the sepsis was attributed to B. zoohelcum and ciprofloxacin 750 mg every 12 h was added to the regimen.
However, due to the rareness of the pathogen, the isolate was re-identified using Vitek 2 system (bioMérieux, Inc., Durham, N.C., USA) Gram-negative card as B. melitensis with a 99% probability. Subsequently, the isolate was referred for 16S ribosomal sequence analysis. The isolate was identified as B. melitensis with 100% match. The patient's serum was also positive for presence of Brucella antibody by Brucella microagglutination test with a titer of 1: 640. Further detailed history revealed that the patient had close contact with dogs kept as pets in his home and goats in his farm. The patient's hepatitis profile and HIV antibody status were negative.
Discussion
Accurate and rapid identification of Brucella spp. is necessary to provide appropriate treatment to the affected individual and take necessary measures to prevent laboratory-acquired infections [7] . In this case, a Brucella isolate was picked up by the BACTEC system from blood within 48 h; however, the isolate was misidentified as B. zoohelcum by MicroScan WalkAway. In recent times, automated microbial detection systems like BACTEC 9240 and BacT/ALERT have increased the speed, effectiveness and reliability of Brucella isolation from clinical specimens [3] . However, identification of Brucella species using commercial rapid identification systems has remained inconsistent and challenging [4] [5] [6] 8] . This might be due to several reasons including relative biochemical inactivity of the pathogen, failure to incorporate identifying characteristics of Brucella species into their databases and lack of suitable panels for its accurate identification [9] .
In our case, the isolate was reidentified as B. melitensis by the Vitek 2 system and later confirmed by 16S rRNA analysis with a match of 100%. The patient's serum was also positive for Brucella antibody using the Brucella microagglutination test having a titer of 1: 640. This showed that the diagnosis of human brucellosis can be challenging and laboratories should use a range of tests including molecular techniques to reach a confirmative etiological diagnosis [8] .
Because brucellosis is prevalent in the Middle East, to our knowledge, most laboratories in this region use automated microbial detection and identification systems in their setups and MicroScan WalkAway remains a very popular choice. However, the MicroScan WalkAway system (Siemens Healthcare Diagnostics Inc.) can misidentify Brucella species as some other pathogen like B. zoohelcum in our case. We believe that such identification ambiguity can create uncertainties surrounding the use of bacterial identification systems for identifying Brucella during routine laboratory testing. Because of this inappropriate identification of Brucella species by various commercial rapid identification systems, the sentinel laboratory guidelines for suspected agents of bioterrorism prepared by the American Society of Microbiology do not recommend the use of commercial identification systems for Brucella identification [10] .
Misidentification of Brucella spp. in the laboratory does carry a high risk of laboratory-acquired infections [7] due to aerosol generation and exposure among the laboratory personnel. In order to avoid such incidents in our laboratories, we suggest that whenever a Gram-negative coccobacillus is isolated from blood and bone marrow cultures, the laboratory staff should inform the laboratory director and further handling of the pathogen should be carried out in the biosafety cabinet to perform catalase, oxidase and slide agglutination tests. The confirmatory tests should be performed in a biosafety level 3 reference laboratory instead.
Conclusion
This case showed that Brucella was misidentified as B. zoohelcum by the MicroScan WalkAway system. This can result in inaccurate identification of the true pathogen and inappropriate treatment of the patient. Laboratories using MicroScan WalkAway systems need to be careful enough not to miss the diagnosis of Brucella till the deficits of the system are addressed.
